Hepion Pharmaceuticals
HEPA
#10558
Rank
C$1.28 M
Marketcap
C$0.11
Share price
14.29%
Change (1 day)
-99.75%
Change (1 year)

Earnings for Hepion Pharmaceuticals (HEPA)

Earnings in 2025 (TTM): -C$11.98 Million

According to Hepion Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -C$21.49 Million, an increase over its 2023 earnings that were of -C$68.23 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Hepion Pharmaceuticals from 2014 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$11.98 Million-44.28%
2024 -C$21.49 Million-68.5%
2023 -C$68.23 Million9.74%
2022 -C$62.18 Million37.49%
2021 -C$45.22 Million61.27%
2020 -C$28.04 Million174.55%
2019 -C$10.22 Million-31.28%
2018 -C$14.87 Million
2016 -C$29.5 Million6.03%
2015 -C$27.82 Million265%
2014 -C$7.63 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-C$0.21 Billion 1,610.85%๐Ÿ‡บ๐Ÿ‡ธ USA